يرجى استخدام متصفح الكمبيوتر الشخصي للوصول إلى التسجيل - تداول السعودية
حسنًا
Morgan Stanley Maintains Overweight on Mirum Pharmaceuticals, Raises Price Target to $81
Mirum Pharmaceuticals +4.60%
Mirum Pharmaceuticals MIRM | 67.05 | +4.60% |
Morgan Stanley analyst Michael Ulz maintains Mirum Pharmaceuticals (NASDAQ:
MIRM) with a Overweight and raises the price target from $75 to $81.
